Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. STKE, 17 July 2007
Vol. 2007, Issue 395, p. tw255
[DOI: 10.1126/stke.3952007tw255]

EDITORS' CHOICE

Structural Biology Crystallized Kinase Regulation

Valda Vinson

Science, AAAS, Washington, DC 20005, USA

Many human cancers involve gain-of-function mutations in the phosphoinositide 3-kinase PI3K{alpha}. The kinase is a heterodimer of a catalytic subunit (p110{alpha}) and a regulatory subunit (p85{alpha}), with both subunits comprising multiple domains. Miled et al. (see the Perspective by Lee et al.) have determined the crystal structure of the adaptor binding domain of p110{alpha} bound to the inter-SH2 domain of p85{alpha} at 2.4 angstrom resolution and have performed functional studies to investigate the effect of oncogenic mutations in the helical domain of p110{alpha} on its interaction with the N-terminal SH2 domain of p85{alpha}. The studies suggest how these two classes of mutations cause the up-regulation of PI3K{alpha} that can lead to cancer.

N. Miled, Y. Yan, W.-C. Hon, O. Perisic, M. Zvelebil, Y. Inbar, D. Schneidman-Duhovny, H. J. Wolfson, J. M. Backer, R. L. Williams, Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit. Science 317, 239-242 (2007). [Abstract] [Full Text]

J. Y. Lee, J. A. Engelman, L. C. Cantley, PI3K charges ahead. Science 317, 206-207 (2007). [Summary] [Full Text]

Citation: V. Vinson, Crystallized Kinase Regulation. Sci. STKE 2007, tw255 (2007).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882